KOPRAN
Quarterly Results Analysis [Jun2024]
KOPRAN Quarterly Results
Consolidated | Jun2024 UnAudited |
Mar2024 UnAudited |
Dec2023 UnAudited |
Sep2023 UnAudited |
Jun2023 UnAudited |
Mar2023 Audited |
Dec2022 UnAudited |
Sep2022 Audited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹139 Cr | ₹186 Cr | ₹159 Cr | ₹153 Cr | ₹117 Cr | ₹149 Cr | ₹158 Cr | ₹117 Cr |
Expenses | ₹121 Cr | ₹164 Cr | ₹135 Cr | ₹130 Cr | ₹111 Cr | ₹137 Cr | ₹146 Cr | ₹107 Cr |
Operating Income | ₹18 Cr | ₹22 Cr | ₹24 Cr | ₹23 Cr | ₹6 Cr | ₹12 Cr | ₹12 Cr | ₹10 Cr |
Other Income | ₹3 Cr | ₹10 Cr | ₹2 Cr | ₹0 Cr | ₹2 Cr | ₹4 Cr | ₹2 Cr | ₹0 Cr |
Interest | ₹2 Cr | ₹3 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹1 Cr |
Depreciation | ₹4 Cr | ₹4 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr |
Profit Before Tax | ₹15 Cr | ₹25 Cr | ₹21 Cr | ₹18 Cr | ₹4 Cr | ₹11 Cr | ₹9 Cr | ₹6 Cr |
Profit After Tax | ₹11 Cr | ₹19 Cr | ₹16 Cr | ₹14 Cr | ₹3 Cr | ₹8 Cr | ₹7 Cr | ₹5 Cr |
EPS | ₹2.30 | ₹3.86 | ₹3.28 | ₹2.86 | ₹0.58 | ₹1.67 | ₹1.44 | ₹0.97 |
Industry Peers & Returns | 1W | 1M | 1Y |
KOPRAN | 5.4% | 3.7% | 37.4% |
SUN PHARMACEUTICAL INDUSTRIES | 0.1% | -4% | 52.9% |
CIPLA | 0.5% | -1.7% | 29.4% |
DR REDDYS LABORATORIES | 1.1% | -2.6% | 19.2% |
ZYDUS LIFESCIENCES | -3.6% | -8.4% | 62.9% |
DIVIS LABORATORIES | 0.7% | -0% | 70.9% |
MANKIND PHARMA | -2.8% | -0.7% | 52% |
TORRENT PHARMACEUTICALS | -0.1% | -7.2% | 58.1% |
LUPIN | -3.9% | -2.4% | 77.5% |
KOPRAN Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | -25.07 % |
Y-o-Y | 19.17 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Jun2024 | ₹139 Cr | -25.07 | |
Mar2024 | ₹186 Cr | 17.09 | |
Dec2023 | ₹159 Cr | 4.15 | |
Sep2023 | ₹153 Cr | 30.42 | |
Jun2023 | ₹117 Cr | -21.41 | |
Mar2023 | ₹149 Cr | -5.78 | |
Dec2022 | ₹158 Cr | 35.08 | |
Sep2022 | ₹117 Cr | - |
KOPRAN Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | -16.27 % |
Y-o-Y | 187.74 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Jun2024 | ₹18 Cr | -16.27 | |
Mar2024 | ₹22 Cr | -8.01 | |
Dec2023 | ₹24 Cr | 3.31 | |
Sep2023 | ₹23 Cr | 261.63 | |
Jun2023 | ₹6 Cr | -48.09 | |
Mar2023 | ₹12 Cr | -1.31 | |
Dec2022 | ₹12 Cr | 21.46 | |
Sep2022 | ₹10 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | 11.75 % |
Y-o-Y | 141.74 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Jun2024 | 13.03% | 11.75 | |
Mar2024 | 11.66% | -21.43 | |
Dec2023 | 14.84% | -0.80 | |
Sep2023 | 14.96% | 177.55 | |
Jun2023 | 5.39% | -34.03 | |
Mar2023 | 8.17% | 4.74 | |
Dec2022 | 7.8% | -10.03 | |
Sep2022 | 8.67% | - |
KOPRAN Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | -40.42 % |
Y-o-Y | 300.07 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Jun2024 | ₹11 Cr | -40.42 | |
Mar2024 | ₹19 Cr | 17.90 | |
Dec2023 | ₹16 Cr | 14.70 | |
Sep2023 | ₹14 Cr | 396.54 | |
Jun2023 | ₹3 Cr | -65.51 | |
Mar2023 | ₹8 Cr | 15.72 | |
Dec2022 | ₹7 Cr | 49.24 | |
Sep2022 | ₹5 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | -20.48 % |
Y-o-Y | 235.86 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Jun2024 | 7.96 % | -20.48 | |
Mar2024 | 10.01 % | 0.70 | |
Dec2023 | 9.94 % | 10.20 | |
Sep2023 | 9.02 % | 280.59 | |
Jun2023 | 2.37 % | -56.11 | |
Mar2023 | 5.4 % | 22.73 | |
Dec2022 | 4.4 % | 10.55 | |
Sep2022 | 3.98 % | - |
KOPRAN Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | -40.41 % |
Y-o-Y | 296.55 % |
Quarters | EPS | % Change | |
---|---|---|---|
Jun2024 | ₹2.3 | -40.41 | |
Mar2024 | ₹3.86 | 17.68 | |
Dec2023 | ₹3.28 | 14.69 | |
Sep2023 | ₹2.86 | 393.10 | |
Jun2023 | ₹0.58 | -65.27 | |
Mar2023 | ₹1.67 | 15.97 | |
Dec2022 | ₹1.44 | 48.45 | |
Sep2022 | ₹0.97 | - |
You may also like the below Video Courses